Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.
Transpl Int
; 35: 10228, 2022.
Article
in En
| MEDLINE
| ID: mdl-35497889
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kidney Transplantation
/
Thrombotic Microangiopathies
/
Graft vs Host Disease
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Transpl Int
Journal subject:
TRANSPLANTE
Year:
2022
Document type:
Article
Affiliation country:
France
Country of publication:
Switzerland